In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones
Saved in:
| Title: | In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones |
|---|---|
| Authors: | Masimo |
| Source: | Business Wire (English). 10/07/2025. |
| Abstract: | Masimo (NASDAQ: MASI) today announced the findings of an exploratory analysis for a unique feasibility study published in CHEST Critical Care in which Dr. Andrew Goodwin and colleagues at the Medical University of South Carolina (MUSC) found that Masimo SET® pulse oximetry performed accurately among critically ill adult patients of all skin tones, including those with low perfusion requiring vasopressors – and reported zero occult hypoxemic events.1 [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Masimo (NASDAQ: MASI) today announced the findings of an exploratory analysis for a unique feasibility study published in CHEST Critical Care in which Dr. Andrew Goodwin and colleagues at the Medical University of South Carolina (MUSC) found that Masimo SET® pulse oximetry performed accurately among critically ill adult patients of all skin tones, including those with low perfusion requiring vasopressors – and reported zero occult hypoxemic events.1 [ABSTRACT FROM PUBLISHER] |
|---|
